Federal Register Notice: FDA is reopening until 10/17, the comment period for Draft Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays published in the 7/26 Federal Register. To view this notice, click here.
